Information Provided By: 
Fly News Breaks for October 22, 2015
STJ
Oct 22, 2015 | 07:41 EDT
Canaccord lowered its price target on St. Jude Medical to $59 from $64 following what it views as "underwhelming" Q3 results. The firm reiterated its Sell rating based on the company's lower guidance and increasing concerns about its competitiveness near term in CRM and its ability to ramp CardioMEMS revenue.
News For STJ From the Last 2 Days
There are no results for your query STJ
